Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes
about
Astragalus polysaccharide suppresses doxorubicin-induced cardiotoxicity by regulating the PI3k/Akt and p38MAPK pathways.Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and OutcomesPrognostic Value of Galectin-3 for Adverse Outcomes in Chronic Heart FailureAssociation of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial.Epidemiology of "Heart Failure with Recovered Ejection Fraction": What do we do After Recovery?Kyoto Congestive Heart Failure (KCHF) study: rationale and designSpectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review.Abnormal Global Longitudinal Strain Predicts Future Deterioration of Left Ventricular Function in Heart Failure Patients With a Recovered Left Ventricular Ejection Fraction.Left ventricular assist device-induced reverse remodeling: it's not just about myocardial recovery.Transcriptional patterns of reverse remodeling with left ventricular assist devices: a consistent signature.After TOPCAT: What to do now in Heart Failure with Preserved Ejection Fraction.Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study.Biomarkers to Predict Reverse Remodeling and Myocardial Recovery in Heart Failure.Effect of Heart Failure With Preserved Ejection Fraction on Nitric Oxide Metabolites.Korean Guidelines for Diagnosis and Management of Chronic Heart Failure.Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain).Reverse remodelling and myocardial recovery in heart failure.Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.Epidemiology, pathophysiology and clinical outcomes for heart failure patients with a mid-range ejection fraction.Characteristics and prognosis of heart failure with improved compared with persistently reduced ejection fraction: A systematic review and meta-analyses.Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.Recovery in Patients With Dilated Cardiomyopathy With Loss-of-Function Mutations in the Titin Gene.Gaps in the Heart Failure Guidelines
P2860
Q34438288-DBE07DF0-65C9-4351-AF61-CD18E0529984Q36728719-782F8310-FAF7-426A-BE7B-8D477D742CB8Q36757833-16908D0C-E2C4-4C98-8F12-B1949303DE34Q38373676-89CF088E-6403-44F1-B6DE-47737EE9057CQ38612603-2F3C52D0-85DB-47D2-8658-51248FB2395EQ38643986-5748F934-11F4-41E8-8485-4285E810179CQ38658569-038B5B06-8C34-4023-8A79-A1296105EB63Q38677002-5BBF6C75-06FA-4940-BB80-16651B1006FAQ38792510-9C71EA26-C599-41DD-993A-E79BF5090585Q38800048-FE2BB7E5-26AA-4F66-B510-DC45B640D10AQ38807777-B19CC625-9A77-473C-948D-9A8B41FD7BEDQ38859108-5A64EEBC-3093-4E0D-9AA9-9029260A5104Q38977493-95459F98-380D-487C-B1AF-A590BF472D6BQ40541500-7C1C213E-82B6-4F29-8EBE-2D99F6504EEDQ41686228-2BCFB926-8556-42A9-8080-2F860C03D3B5Q47186244-08790D3C-CEB1-478E-AB85-BDE6B6139621Q47652227-5F98FE6E-20C6-490A-AED0-35909DD908BFQ48119758-3B8589A4-094D-440C-B80A-CB7254BB4407Q48513189-317DB666-969F-4176-A002-689DEDD5CACAQ50127271-53025371-190F-4639-8D8A-03A8986E8DC4Q50926906-6BFADAE4-E7E4-49B0-94B6-24808AEDAC84Q53347615-D06DE323-89BF-4606-8CA8-CA54B34D9A70Q57630227-E87BEA71-D2BD-45F2-AFBD-F749ED846C5E
P2860
Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Heart failure with recovered e ...... tion, biomarkers, and outcomes
@ast
Heart failure with recovered e ...... tion, biomarkers, and outcomes
@en
type
label
Heart failure with recovered e ...... tion, biomarkers, and outcomes
@ast
Heart failure with recovered e ...... tion, biomarkers, and outcomes
@en
prefLabel
Heart failure with recovered e ...... tion, biomarkers, and outcomes
@ast
Heart failure with recovered e ...... tion, biomarkers, and outcomes
@en
P2093
P2860
P1433
P1476
Heart failure with recovered e ...... tion, biomarkers, and outcomes
@en
P2093
Anupam Basuray
Benjamin French
Caroline Olt
Esther Vorovich
James C Fang
Thomas P Cappola
P2860
P304
P356
10.1161/CIRCULATIONAHA.113.006855
P407
P50
P577
2014-05-05T00:00:00Z